Literature DB >> 790185

The virus of hepatitis, type B. (Second of two parts).

W S Robinson, L I Lutwick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 790185     DOI: 10.1056/NEJM197611252952206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Progress with hepatitis B virus-editorial review.

Authors:  W S Robinson
Journal:  West J Med       Date:  1978-02

Review 2.  Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Authors:  G Yang; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

3.  Antibodies to pre-S and X determinants arise during natural infection with ground squirrel hepatitis virus.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

4.  Hepatitis B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide.

Authors:  B E Eble; V R Lingappa; D Ganem
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

Review 5.  Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread.

Authors:  P Karayiannis
Journal:  Hepatol Int       Date:  2017-11-02       Impact factor: 6.047

6.  Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice.

Authors:  L G Guidotti; V Martinez; Y T Loh; C E Rogler; F V Chisari
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Expression and characterization of hepatitis B virus surface antigen polypeptides in insect cells with a baculovirus expression system.

Authors:  R E Lanford; V Luckow; R C Kennedy; G R Dreesman; L Notvall; M D Summers
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

Review 9.  Blood protein derivative viral safety: observations and analysis.

Authors:  B Horowitz
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct

Review 10.  Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.

Authors:  Natasha Kushnir; Stephen J Streatfield; Vidadi Yusibov
Journal:  Vaccine       Date:  2012-11-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.